Murphy & Mullick Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194K Buy
402
+8
+2% +$2.12K 0.12% 142
2026
Q1
$43.2K Buy
394
+32
+9% +$4.56K 0.03% 303
2025
Q4
$60.2K Buy
362
+32
+10% +$5.35K 0.04% 266
2025
Q3
$57.7K Buy
330
+40
+14% +$6.58K 0.04% 263
2025
Q2
$28.8K Sell
290
-35
-11% -$2.77K 0.02% 331
2025
Q1
$19.4K Hold
325
0.02% 371
2024
Q4
$43K Buy
+325
New +$30.5K 0.04% 268

Other funds holding ALAB

Murphy & Mullick Capital Management's ALAB Position: Q2 2026 in Review

Murphy & Mullick Capital Management increased its Astera Labs (ALAB) stake by 2% in Q2 2026, buying an estimated $2.12K and bringing the position to 402 shares worth $194K. The position accounts for 0.12% of the portfolio, ranked #142.

Murphy & Mullick Capital Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Murphy & Mullick Capital Management held 402 shares of Astera Labs worth $194K as of Q2 2026.
  • Murphy & Mullick Capital Management bought 8 Astera Labs shares in Q2 2026, an estimated $2.12K.
  • Astera Labs made up 0.12% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #142 holding.
  • Murphy & Mullick Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.